Alternate Health Club Review: What Its GLP-1 Prices Cover—and What Remains Unclear

Alternate Health Club’s advertised monthly prices are only the beginning of its cost story. The more consequential detail is that its standard semaglutide process collects payment when the intake is submitted, before a clinician decides whether to prescribe. Meanwhile, its product page describes a vial designed for 28 days but labels the price monthly. For someone comparing recurring expenses, those details matter as much as the headline number: they affect when money leaves the account, what it buys and what remains unresolved.

AHC presents itself as an online service coordinating individual clinical review and compounded medication for weight management and maintenance. This review examines the documents consulted October 19, 2026, rather than testing the service or verifying its professional credentials. The pages provide useful specifics about formulations, optional charges and delivery, but do not consistently describe consultations or inclusions. They also leave renewal mechanics and cancellation procedures unclear. The practical task is to separate an advertised starting price from a complete, written purchasing agreement.

At a glance

Standard advertised prices: Weekly subcutaneous compounded semaglutide with B12 starts at $129 per month; compounded tirzepatide with B12 starts at $169 per month. Both product pages describe vials designed for 28 days.
Sources: [5] [8]
Microdose pricing: Separate semaglutide and tirzepatide microdose programs are advertised at $99 per month each; the microdose page says availability does not extend to all 50 states.
Sources: [9]
Payment precedes approval: The standard semaglutide flow collects payment with the intake. Payment submits an order for clinical review and does not guarantee medication.
Sources: [5]
Optional consultation: The semaglutide page lists direct consultation with a licensed clinician for $29.99 before or during treatment and says optional services cost extra.
Sources: [5]
Refund limits: AHC’s terms make consultation, medical-review and administrative fees nonrefundable upon submission, with all charges nonrefundable once review is completed or pharmacy fulfillment begins.
Sources: [10]

Start with the product—not the lowest number

AHC’s standard semaglutide listing advertises compounded semaglutide with vitamin B12 from $129 per month. Its standard tirzepatide listing advertises compounded tirzepatide with B12 from $169 per month. Both describe weekly subcutaneous injections. These are starting prices for specified compounded formulations, not quotes for FDA-approved branded products. AHC separately says it charges the same monthly rate across dosage tiers, with no membership fee; that commercial promise should still be reconciled with the starting-at wording in a personal quote.

The $99 figure belongs to separately listed microdose programs for semaglutide and tirzepatide. AHC describes the tirzepatide microdose plan primarily as maintenance and stability support, not active weight loss. Its semaglutide microdose page identifies compounded semaglutide plus B12. These listings should not be treated as interchangeable versions of the standard programs merely because their names share an ingredient. The actual program and presentation need to appear on the order before its price becomes a useful comparison.

A further inconsistency makes product-level confirmation worthwhile: the general weight-loss page has a starting-at-$99 title while its main content advertises starting at $129 monthly. The separate microdose listings explain where $99 appears elsewhere, but do not resolve that page’s mismatch. The table below separates the documented offers without assuming that the lowest advertised figure applies to everyone or that a monthly label establishes the quantity or duration of medication supplied.

AHC’s documented advertised prices
Offering	Advertised charge	Important qualification
Compounded semaglutide with B12	From $129 per month	Weekly subcutaneous injection; vial designed for 28 days
Compounded tirzepatide with B12	From $169 per month	Weekly subcutaneous injection; vial designed for 28 days
Semaglutide microdose	$99 per month	Separate program; compounded semaglutide plus B12
Tirzepatide microdose	$99 per month	Described primarily for maintenance and stability
Optional direct clinician consultation	$29.99	Listed on the standard semaglutide page

Sources: [5] [8] [9] [11] [3] [12]

The first payment buys a review, not guaranteed medication

The standard semaglutide workflow is unusually important to the budget: complete the intake, pay on submission and then receive clinical review. A licensed clinician retains discretion to approve or decline based on medical history. AHC explicitly says payment does not guarantee medication and that support will contact the customer if the order is declined. It does not specify in the supplied documentation exactly how much would then be retained or returned.

The terms identify the business as Alternate Health Club, LLC. AHC says clinical services come from independently contracted, U.S.-licensed clinicians, and that completing an assessment does not itself create a doctor-patient relationship. Its site-use terms restrict registration to adults 18 and older, but that is not a complete medication-eligibility policy. The supplied pages do not establish full medical criteria, laboratory requirements or the identity of the clinician who would review a particular order.

Before submitting payment, request an itemized explanation of the medication, review, administration and any additional services, including what happens financially after a declined application. Our guide to understanding the first GLP-1 payment provides a useful framework for that conversation. Here, the key distinction is especially concrete: money is collected before the prescribing decision, while some service fees are described as earned immediately.

Sources: [10] [4] [5]

Included review and paid conversation are different benefits

The semaglutide product page includes review of the medical intake, a treatment plan based on history and goals, a prescription only when medically appropriate, and cold-chain express shipping. It says the standard flow does not require a video call. Direct conversation with a licensed clinician is separately available for $29.99 before or during treatment. That distinction matters for anyone who expects the advertised price to include a live discussion rather than a review of submitted information.

Other pages are less consistent. The general weight-loss description discusses meeting by phone or video, while general FAQs describe a scheduled video call. A cost calculator advertises no consultation charges, and another calculator invites a free consultation. These statements do not establish which conversation is included in a particular purchase. The product-specific $29.99 listing is a documented charge that should not disappear from a budget simply because broader marketing uses the word free.

There is a similar conflict around nausea support. General FAQs describe broad monthly inclusions and mention nausea medication, but the semaglutide listing makes ondansetron ODT optional and separately available. The sample also does not confirm needles and other supplies in every order. AHC says additional supplements are not required. Use an included-costs checklist to obtain a written list, rather than treating broad all-inclusive language as confirmation of every accessory, medicine or consultation.

Sources: [5] [12] [7] [6]

A monthly price does not settle the renewal calendar

AHC describes each standard semaglutide and tirzepatide vial as designed to cover 28 days. Its price labels say per month, while general FAQs describe automatic monthly shipments according to the prescription after visits. Those statements do not establish whether charges recur every 28 days, on a calendar-month anniversary or on another schedule. The distinction is not semantic: a four-week supply and a calendar month are different periods, even when a provider uses monthly language for both.

The general FAQs say only one month is shipped at a time, attributing that limit to sterile-compounding rules. That is AHC’s description, not independent regulatory verification. Refills remain subject to clinical assessment and the ongoing plan. The semaglutide page also says treatment duration varies individually and has no fixed timeline. Neither shipment size nor an open-ended clinical timeline establishes a minimum purchasing commitment, and the supplied sample documents no specific prepayment package or commitment period.

The missing financial details are the renewal date, authorization for recurring charges, cancellation method and deadline for stopping the next shipment. No notice period can responsibly be supplied from these documents. Ask AHC to align the charge date, prescribed supply period and shipment schedule in writing. Our explanation of monthly versus four-week billing helps distinguish those moving parts without assuming a billing interval that AHC’s available pages have not settled.

Sources: [5] [8] [12] [7]

Refund exposure begins before a package ships

AHC’s terms say consultation, medical-review and administrative-processing fees are earned on submission and nonrefundable. They further say all fees become nonrefundable once provider review is completed or pharmacy fulfillment begins. The product page describes prescription sales as final and directs customers to support for suspected filling errors. Those provisions make the point of payment important: the financial cutoff is not simply delivery, and stopping future service would not automatically reverse an earlier charge.

There is one specific microdose exception. All customers, including existing patients, must submit the dedicated microdosing intake form; the page promises cancellation and a full refund for orders submitted without it. That narrow promise should not be generalized into a trial period or broad satisfaction guarantee. Where refunds are issued, AHC says they typically take three to five business days depending on the bank—not that every eligible customer is guaranteed money in their account within that window.

Shipping exclusions add another layer. The terms deny refunds for delays, carrier problems, weather, missed delivery, incorrect shipping information and theft. Another clause assigns responsibility for condition, storage, handling and timely delivery once medication reaches AHC or its agents from the pharmacy. This describes the contract language, not a judgment about enforceability. Before ordering, separate cancellation from refund eligibility and ask what remedy AHC offers for a damaged, missing or temperature-compromised shipment.

Sources: [3] [5] [10]

Pharmacy and delivery arrangements affect the value received

AHC says it does not manufacture medication and that licensed U.S. pharmacies dispense it. Its footer describes partners as state-licensed and NABP-accredited; its terms describe affiliated 503A compounding pharmacies. The supplied evidence does not name the pharmacy that would fill a specific order or independently verify those credentials. The terms also tie advertised pricing to affiliated pharmacies and warn that another pharmacy may cost more. This is not a documented freely transferable medication price.

The terms authorize AHC or its agents to receive dispensed medication from the pharmacy, package it and forward it through a commercial carrier. The semaglutide page advertises typical processing in one to two business days and average delivery in four to twelve business days, within the United States only. These are distinct estimates, not a guaranteed arrival date or a clinical-review turnaround. Included cold-chain express shipping therefore needs to be evaluated alongside the separate allocation of shipping risk.

AHC says ice packs provide a temperature buffer and need not arrive frozen. That statement does not establish that any warm shipment is suitable for use. FDA explicitly advises not using an injectable GLP-1 product that arrives warm or inadequately refrigerated and contacting the provider or dispensing pharmacy. Obtaining the dispensing pharmacy’s name and a clear temperature-problem contact process before payment would make both the delivery promise and the potential replacement cost easier to assess.

Sources: [4] [10] [5] [1]

Follow-up, location and payment eligibility need separate confirmation

For clinical questions and treatment-change requests, AHC directs customers through website live chat or email support. It says its medical officer reviews every dosage-change request so a licensed reviewer sees it. The site also promotes centralized tracking of refills, shipments and progress. These are useful descriptions of routing and account management, but the evidence supplies no required follow-up frequency, guaranteed support response time or assurance that every subsequent consultation is covered by the advertised medication price. The supplied terms also say the site is not adapted to comply with regulations such as HIPAA and restrict interactions subject to them, while the site includes HIPAA links and protected-health-information authorizations. This evidence does not establish HIPAA compliance or noncompliance; ask AHC which channel is intended for medical information and what protections apply.

Geography also requires product-specific checking. AHC’s calculator advertises shipping to all 50 states, while its microdose page expressly says the program is not available in all 50. The excluded states are not identified in the supplied sample. A microdose applicant should therefore confirm state availability before payment rather than relying on the broader national claim. Previous GLP-1 experience is not presented as universally necessary for microdosing; eligibility remains a clinician’s decision based on the intake.

AHC’s calculator says many patients may use HSA or FSA funds but instructs them to confirm eligibility with their plan administrator. That is neither confirmation of insurance acceptance nor a coverage promise. The supplied documents do not establish insurer billing or individual benefits. For an accurate budget, keep three questions separate: what AHC charges, whether a particular account can pay it and whether any insurance plan reimburses anything. None is answered automatically by the other two.

Sources: [3] [5] [12] [6] [9] [4]

Price clarity is not evidence of clinical equivalence

AHC acknowledges that its compounded preparations are not FDA approved and says they are prescribed when a clinician determines commercially available options cannot meet the patient’s needs. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and state-licensed pharmacy. Compounded preparations do not undergo FDA premarket review for safety, effectiveness and quality. Their nonapproval alone does not establish clinical inequivalence, but neither does a low price establish equivalence.

AHC’s calculator acknowledges that the trials behind its projections studied branded medicines rather than its compounded versions. The supplied evidence contains no provider-specific clinical outcomes establishing results for these B12 blends or microdose programs. Consequently, projected weight change should not be treated as a return on the monthly payment. AHC also lists other medications separately from its compounds; product approvals do not confer FDA approval on AHC itself or on the compounded weight-management offerings.

NIDDK describes medication selection as a discussion of benefits, side effects, health conditions, other medicines and costs; follow-up concerns tolerance and response, not merely renewal. FDA also reports measurement and administration errors with compounded GLP-1 medication, some involving hospitalization. Readers should clarify instructions with their prescriber or pharmacist rather than derive them from a review. Financially, that makes accessible clinical guidance a substantive part of value—not an optional detail to consider only after comparing advertised medication prices.

Sources: [4] [6] [1] [2]

Questions & answers

Is AHC’s $129 semaglutide price an introductory offer?

The product page describes a starting monthly price, not a documented introductory discount followed by a specified higher renewal price. AHC also advertises the same monthly rate across dosage tiers and no membership fee. That does not resolve billing dates or every optional charge. Request the initial total and subsequent charge schedule together.

Sources: [5]

Will AHC return my entire payment if prescribing is declined?

The supplied pages do not specify the amount returned after a clinical rejection. AHC says support will contact customers whose orders are declined, while its terms make several service fees nonrefundable on submission. Obtain the rejection-refund calculation before paying; the separate full-refund promise for a missing microdose intake does not answer this question.

Sources: [5] [10] [3]

Does the monthly price include speaking directly with a clinician?

The standard semaglutide page includes intake review but separately lists a direct consultation for $29.99. Other pages describe phone or video evaluation and free or no-fee consultations. Because these descriptions conflict, ask which interaction your particular order includes and whether an additional conversation before or during treatment carries the listed charge.

Sources: [5] [12] [6]

Can an existing AHC patient order microdoses without another intake?

No, according to the microdose page: existing patients also need the dedicated Microdosing Intake Form. It says orders without that completed form will be canceled and fully refunded. Clinical eligibility is still individually determined, and availability is not nationwide. An existing account or previous prescription therefore does not by itself establish access to the separate program.

Sources: [3] [9]

Can I use a different pharmacy and keep AHC’s advertised price?

AHC’s terms connect its prices to affiliated pharmacies and warn that using another pharmacy may result in higher costs it cannot control or guarantee. The documentation does not establish a price-matched outside-pharmacy option. Ask which pharmacy will dispense your order and whether any separately billed services would apply before treating the advertised figure as your total.

Sources: [10] [4]

How do I stop the next AHC charge or shipment?

The supplied sample does not document a cancellation procedure or a deadline for stopping renewal. General FAQs describe automatic monthly shipments, making written confirmation especially important. Ask support how to stop both future billing and pharmacy fulfillment, and request confirmation. Do not assume that canceling future service creates a refund for review or fulfillment already performed.

Sources: [7] [10]

Our assessment

AHC documents meaningful price details: specified compounded B12 formulations, starting monthly charges, a separate microdose tier, included clinical review and shipping, and a $29.99 optional consultation. Its flat-rate and no-membership claims make comparison easier. The weaker point is the complete transaction: payment precedes approval, refund exposure starts early, and renewal, cancellation and several inclusions remain unresolved or inconsistent. A useful next step is a written, product-specific quote covering the first charge, recurring interval, consultation access, supplies, dispensing pharmacy and cancellation cutoff. Until those answers are supplied, AHC’s advertised price is a starting point for budgeting—not a fully documented recurring cost.

Visit Alternate Health Club (AHC)’s official site ↗

This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

Alternate Health Club Review: What Its GLP-1 Prices Cover—and What Remains Unclear

At a glance

01Start with the product—not the lowest number

02The first payment buys a review, not guaranteed medication

03Included review and paid conversation are different benefits

04A monthly price does not settle the renewal calendar

05Refund exposure begins before a package ships

06Pharmacy and delivery arrangements affect the value received

07Follow-up, location and payment eligibility need separate confirmation

08Price clarity is not evidence of clinical equivalence